NCT00003080: Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer |
|
|
| Completed | 1 | | US | endocrine-modulating drug therapy, melphalan, mitoxantrone hydrochloride, tamoxifen citrate, thiotepa, peripheral blood stem cell transplantation | Fred Hutchinson Cancer Center, National Cancer Institute (NCI) | Ovarian Cancer | 05/01 | 05/01 | | |
NCT00002977: Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission |
|
|
| Completed | 1 | 45 | US | filgrastim, melphalan, thiotepa, peripheral blood stem cell transplantation | Fred Hutchinson Cancer Center, National Cancer Institute (NCI) | Ovarian Cancer | 11/01 | | | |
NCT00550784: Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer |
|
|
| Completed | 1 | 8 | US | filgrastim, cisplatin, cyclophosphamide, melphalan, paclitaxel, topotecan hydrochloride, TdT-mediated dUTP nick end labeling assay, gene expression analysis, immunohistochemistry staining method, pharmacological study, peripheral blood stem cell transplantation | City of Hope Medical Center, National Cancer Institute (NCI) | Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | 10/14 | 10/14 | | |
